Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study

Peer Review reports

Original Submission
16 Mar 2019	Submitted	Original manuscript
29 Apr 2019	Author responded	Author comments - suayib yalcin
24 Dec 2019	Reviewed	Reviewer Report - Teresa Macarulla
12 Jan 2020	Reviewed	Reviewer Report - Jill Lacy
14 Feb 2020	Author responded	Author comments - suayib yalcin
Resubmission - Version 2
29 Apr 2019	Submitted	Manuscript version 2
1 Mar 2020	Reviewed	Reviewer Report - Jill Lacy
3 Mar 2020	Reviewed	Reviewer Report - Teresa Macarulla
13 Mar 2020	Author responded	Author comments - suayib yalcin
Resubmission - Version 3
13 Mar 2020	Submitted	Manuscript version 3
Publishing
17 Mar 2020	Editorially accepted
30 Mar 2020	Article published	10.1186/s12885-020-06758-9

Back to article page